Category Archives: Multidistrict Litigation

Multidistrict litigation (MDL) involves complex litigation proceedings that are not consolidated into one single court hearing like in class action.

Daily Fantasy Sports Legalized In Indiana? Does That Mean It Should Be Legal In Other States?

Daily fantasy sports continues to stew in a pot of controversy, but progress is being made as lawmakers sort through the legal details of the highly popular online activity. States like Virginia and Indiana have just signed DFS bills into law, but the differences in these laws could leave the fate of DFS uncertain. Daily Fantasy Sports Legalized In Indiana and Virginia On the surface, new laws created by Indiana and Virginia look similar. Both laws set a minimum age limit of 18, both laws institute a $50,000 registration fee for DFS companies, but the difference in these bills won’t help other states figure out how they are going to treat the gaming sensation. What Do These DFS Bills Mean? In Virginia, DFS will be regulated by the Department of Agriculture and Consumer Services because the bill says that DFS is a skill-based hobby. However, Indiana seems to be calling…
Read More »

Posted in Multidistrict Litigation | Tagged | Leave a comment

Even More Cases of Patient Bleeding Found in Revised Pradaxa Study

According to Bloomberg News, a new analysis of a Pradaxa study funded by Boehringer Ingelheim found 22 serious bleeding events that were not included in their original report. Boehringer Ingelheim is facing more than 2,000 lawsuits involving the defective drug, a treatment used to prevent strokes in patients who suffer from atrial fibrillation, a heart-rhythm disorder. The Ingelheim, Germany-based company conducted the review after plaintiff’s attorneys revealed that patients who had experienced major bleeding and died while taking Pradaxa were not included in the original trial results. The 18,000-patient study, known as RE-LY, was led by researchers at the Population Health Research Institute in Hamilton, Ontario. They also conducted the final review of the potentially-missed patients identified by 30 Boehringer staff members who combed through over 1,500 cases. Pradaxa became the first alternative to warfarin, the standard of care for over five decades for preventing strokes caused by blood clots,…
Read More »

Posted in Class Action, Multidistrict Litigation, Personal Injury, Pharmaceutical Litigation, Products Liability | Leave a comment

Drug Maker to Pay $100 Million in Dangerous Birth Control Settlement

On February 7, Merck & Co. stated publicly that it will pay $100 million to resolve all product liability lawsuits in the US that allege the company covered up serious health risks involving the NuvaRing intrauterine contraceptive device. The drug, which contains hormones estrogen and progestin, is associated with an increased risk of developing blood clots that can cause heart attacks, strokes or sudden deaths. Available to women in the US since 2001, NuvaRing is one of several contraceptive products linked to this dangerous side effect. Merck, the second-largest drug maker in America, denied any fault under the agreement, which must be accepted by 95 percent of about 3,800 eligible patients involved in lawsuits pending in federal and state courts. Under the settlement, Merck would pay a fraction of what at least one company has paid in a similar settlement recently. German drug maker Bayer AG paid nearly $1.6 billion…
Read More »

Posted in Class Action, Multidistrict Litigation, Pharmaceutical Litigation, Products Liability | Leave a comment

GM Recalls Over 1 Million Vehicles Due to Deadly Defect That Killed 13 Victims

According to The New York Times, General Motors (GM) has recalled nearly 1.4 million cars in the United States, saying that the ignition switch can shut off the car’s engine, electrical system and disable its airbags. Thirteen people have died due to the defect, a warning in what would become a decade-long failure by GM to address a problem that engineers knew about years ago. GM has been sued, and now faces an investigation by the National Highway Traffic Safety Administration (NHTSA) and even the possibility of a criminal investigation. The models involved in the recall include: Chevrolet Cobalt and Pontiac G5 compact cars model years 2005-2007 Saturn Ion compact cars from 2003-2007 Chevy HHR midsized vehicles from 2006-2007 Pontiac Solstice and Saturn Sky sports cars from 2006-2007 This recall is very similar to what happened to Toyota and the deadly sudden unintended acceleration problem in their models. Toyota failed…
Read More »

Posted in Defective Auto Components, Multidistrict Litigation, Products Liability | Leave a comment

Colson Hicks Eidson Attorney Mike Eidson Representing South Florida Man Harmed by OxyElite Pro

Colson Hicks Eidson attorney, Mike Eidson, is representing a man in south Florida who suffered liver failure after taking weight loss drug OxyElite Pro, according to NBC 6 Miami. The man said his life took a terrible turn after he decided to take the diet supplement to lose weight. The man purchased OxyElite Pro, in powder and pill form, at two separate Vitamin Shoppe outlets. The man said the weight loss supplement was working and he lost more than 50 pounds when his health took an unexpected downward spiral. After getting medical attention, his lab test results showed that his liver was in complete failure. The man is now suing The Vitamin Shoppe and USPLabs, the company that makes OxyElite Pro. As we blogged about last week, the US Food and Drug Administration forced USPLabs to recall the product in November; however, Eidson says his client was still able to…
Read More »

Posted in Multidistrict Litigation, Pharmaceutical Litigation | Leave a comment

What Should I Do If I Have Taken a Drug that Has Been Recalled?

Drug manufacturers must exercise reasonable care in the labeling, manufacturing and distribution to medical doctors and pharmacists concerning the risks of their products. If you have taken a drug that has been recalled and have any unusual symptoms that you suspect may be linked to the medicine, see a doctor immediately. After you seek medical attention, contact an experienced attorney that is familiar with pharmaceutical litigation and can fight for your rights. Dietary Supplement OxyElite Pro Recalled Due to Deadly Side Effects A Texas company, USP Labs, has recalled dietary supplement OxyElite Pro, due to dozens of cases of acute liver failure and hepatitis, following actions by the Food and Drug Administration (FDA). Casualties from taking the drug include one death and illnesses so severe that patients required liver transplants. OxyElite Pro is a dietary supplement sold as a fat-burning pill. The supplement was advertised as an aid to losing…
Read More »

Posted in Class Action, Multidistrict Litigation, Pharmaceutical Litigation | Leave a comment